PHAR vs CRMD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
PHAR
CRMD
Investment Advisor Scores
CRMD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PHAR | CRMD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 263.1579 | 39.2157 | CRMD |
| PEG Ratio | 0 | 3.9179 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 20.8% | 156.5% | CRMD |
| Earnings Growth | 74.9% | 6.7% | PHAR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 21.1/100 | 56.0/100 | CRMD |
| Profit Margin | 6.2% | 40.5% | CRMD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG SELL | HOLD | CRMD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PHAR
NeutralMixed signals - no dominant trend phase, RSI 73
CRMD
MarkdownPrice below a falling SMA50 (slope -6.4%), weak momentum, RSI 29
Fundamentals Snapshot
| Metric | PHAR | CRMD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 74.4 | -240.9 |
| Trailing P/E | 41.3 | 2.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 1.6% |
| Gross Margin | 0.9% | 0.9% |
| Operating Margin | 0.3% | 0.4% |
| EPS | 0.32 | 2.05 |
| Dividend Yield | — | — |